ArticleACS bio & med chem Au2026
mSumireF a Monomeric Violet Fluorescent Protein.
Article in ACS bio & med chem Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The development of genetically encoded labels for multicolor experiments requires a diverse palette of fluorescent proteins that are well-behaved. Here, we report mSumireF, a monomeric variant of the violet fluorescent protein Sumire. On its own, the canonical monomerizing valine-to-lysine mutation at residue 206 causes a significant loss of brightness for the mSumire variant. We found that brightness is recovered upon the reversion of mSumire's tyrosine at position 165 back to phenylalanine as in its superfolder GFP grandparent. Importantly, this mSumireF variant exhibits significantly less oligomerization tendency in the organized smooth endoplasmic reticulum (OSER) assay in mammalian cells and in protein solution assays. Furthermore, we demonstrate that an mSumireF donor can be effectively paired with the fluorescent protein acceptors mCerulean3, mTurquoise2, and LSSmScarlet to generate FRET-based ATP biosensors. mSumireF thus provides an improved violet fluorescent protein to expand color options with reduced concern of unwanted dimerization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.